DAIKOKU Tohru

J-GLOBAL         Last updated: Dec 28, 2018 at 18:44
 
Avatar
Name
DAIKOKU Tohru
Affiliation
Hokuriku University
Section
Graduate School of Medicine and Pharmaceutical Sciences for Research
Job title
Associate Professor
Degree
Ph.D.

Research Areas

 
 

Academic & Professional Experience

 
 
   
 
Nagoya University School of Medicine, 1/16/97 to the present
 
 
   
 
Research Institute for Disease Mechanism and Control
 
 
   
 
of Science 4/1/94 to 1/15/97
 
 
   
 
Research Fellow of the Japan Society for the Promotion
 

Education

 
 
   
 
Hokkaido University
 
 
   
 
Graduate School, Nagoya University School of Medicine
 

Published Papers

 
Nawashiro Y, Shiraki K, Yamamoto S, Takizawa K, Sasada Y, Suehiro M, Miura K, Hattori M, Daikoku T, Hisano M
Transplantation proceedings   50(10) 3932-3936   Dec 2018   [Refereed]
Daikoku T, Mizuguchi M, Obita T, Yokoyama T, Yoshida Y, Takemoto M, Shiraki K
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi   51(5) 581-586   Oct 2018   [Refereed]
Fujimoto KJ, Nema D, Ninomiya M, Koketsu M, Sadanari H, Takemoto M, Daikoku T, Murayama T
Antiviral research   154 10-16   Jun 2018   [Refereed]
Itoh A, Sadanari H, Takemoto M, Matsubara K, Daikoku T, Murayama T
Microbiology and immunology   62(5) 341-347   May 2018   [Refereed]
Sadanari H, Fujimoto KJ, Sugihara Y, Ishida T, Takemoto M, Daikoku T, Murayama T
FEBS open bio   8(4) 646-654   Apr 2018   [Refereed]
Akai Y, Sadanari H, Takemoto M, Uchide N, Daikoku T, Mukaida N, Murayama T
Antiviral research   151 105   Mar 2018   [Refereed]
Akai Y, Sadanari H, Takemoto M, Uchide N, Daikoku T, Mukaida N, Murayama T
Antiviral research   148 15-19   Dec 2017   [Refereed]
Aiba N, Shiraki A, Yajima M, Oyama Y, Yoshida Y, Ohno A, Yamada H, Takemoto M, Daikoku T, Shiraki K
Viral immunology   30(7) 500-507   Sep 2017   [Refereed]
Yajima M, Yamada H, Takemoto M, Daikoku T, Yoshida Y, Long T, Okuda T, Shiraki K
Antiviral research   139 95-101   Mar 2017   [Refereed]
Tanaka T, Kamiyama T, Daikoku T, Takahashi K, Nomura N, Kurokawa M, Shiraki K
Acta virologica   61(1) 48-55   2017   [Refereed]
Shiraki K, Toyama N, Daikoku T, Yajima M, Miyazaki Dermatologist Society.
Open forum infectious diseases   4(1) ofx007   2017   [Refereed]
Daikoku T, Tannai H, Honda M, Onoe T, Matsuo K, Onoye Y, Nishizawa M, Kawana T, Okuda T, Hasegawa T, Shiraki K
Journal of dermatological science   82(3) 160-165   Jun 2016   [Refereed]
Yajima M, Shiraki A, Daikoku T, Oyama Y, Yoshida Y, Shiraki K
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy   21(6) 427-433   Jun 2015   [Refereed]
Daikoku T, Oyama Y, Yajima M, Sekizuka T, Kuroda M, Shimada Y, Takehara K, Miwa N, Okuda T, Sata T, Shiraki K
Clinical case reports   3(6) 461-467   Jun 2015   [Refereed]
Nakamura T, Daikoku T, Shiraki K, Hayashi A
Clinical ophthalmology (Auckland, N.Z.)   9 853-858   2015   [Refereed]
Characterization of susceptibility variants of influenza virus grown in the presence of T-705.
Daikoku T, Yoshida Y, Okuda T, Shiraki K
Journal of pharmacological sciences   126(3) 281-284   2014   [Refereed]
Daikoku T, Horiba K, Kawana T, Hirano M, Shiraki K
Journal of medical virology   85(10) 1818-1828   Oct 2013   [Refereed]
Daikoku T, Saito K, Aihara T, Ikeda M, Takahashi Y, Hosoi H, Nishida T, Takemoto M, Shiraki K
Microbiology and immunology   57(5) 396-399   May 2013   [Refereed]
Sasivimolphan P, Lipipun V, Ritthidej G, Chitphet K, Yoshida Y, Daikoku T, Sritularak B, Likhitwitayawuid K, Pramyothin P, Hattori M, Shiraki K
AAPS PharmSciTech   13(4) 1266-1275   Dec 2012   [Refereed]
Himaki T, Masui Y, Chono K, Daikoku T, Takemoto M, Haixia B, Okuda T, Suzuki H, Shiraki K
Antiviral research   93(2) 301-304   Feb 2012   [Refereed]
Shiraki K, Daikoku T, Takemoto M, Yoshida Y, Suzuki K, Akahori Y, Okuno T, Kurosawa Y, Asano Y
Journal of virology   85(16) 8172-8180   Aug 2011   [Refereed]
Lipipun V, Sasivimolphan P, Yoshida Y, Daikoku T, Sritularak B, Ritthidej G, Likhitwitayawuid K, Pramyothin P, Hattori M, Shiraki K
Antiviral research   91(2) 154-160   Aug 2011   [Refereed]
Abaitua F, Daikoku T, Crump CM, Bolstad M, O'Hare P
Journal of virology   85(5) 2024-2036   Mar 2011   [Refereed]
Kuramoto T, Daikoku T, Yoshida Y, Takemoto M, Oshima K, Eizuru Y, Kanda Y, Miyawaki T, Shiraki K
The Journal of pharmacology and experimental therapeutics   333(3) 816-821   Jun 2010   [Refereed]
Iwai M, Yoshida H, Obara M, Horimoto E, Nakamura K, Takizawa T, Kurata T, Mizuguchi M, Daikoku T, Shiraki K
Clinical and vaccine immunology : CVI   17(5) 764-770   May 2010   [Refereed]
Hama Y, Shiraki K, Yoshida Y, Maruyama A, Yasuda M, Tsuda M, Honda M, Takahashi M, Higuchi H, Takasaki I, Daikoku T, Tsumoto T
Journal of virology   84(3) 1616-1624   Feb 2010   [Refereed]
Abaitua F, Souto RN, Browne H, Daikoku T, O'Hare P
The Journal of general virology   90(Pt 10) 2353-2363   Oct 2009   [Refereed]
Akahori Y, Suzuki K, Daikoku T, Iwai M, Yoshida Y, Asano Y, Kurosawa Y, Shiraki K
Journal of virology   83(4) 2020-2024   Feb 2009   [Refereed]
Suzutani T, Nagamine M, Shibaki T, Ogasawara M, Yoshida I, Daikoku T, Nishiyama Y, Azuma M
The Journal of general virology   81(Pt 7) 1763-1771   Jul 2000   [Refereed]
Tsurumi T, Kishore J, Yokoyama N, Fujita M, Daikoku T, Yamada H, Yamashita Y, Nishiyama Y
The Journal of general virology   79 ( Pt 5) 1257-1264   May 1998   [Refereed]
Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo.
Nishiyama Y, Yamada Y, Kurachi R, Daikoku T
Virology   190(1) 256-268   Sep 1992   [Refereed]
Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.
Nishiyama Y, Kimura H, Daikoku T
Journal of virology   65(8) 4520-4524   Aug 1991   [Refereed]
Profiles of enterotoxin and cytotoxin production in Campylobacter jejuni and C.coli.
FEMS Microbiol. Lett. , (1989) Mar.; 49(1):33-36.   
Partial purification and characterization of the enterotoxin produced by Campylobacter jejuni.
Infect. Immun. (1990) Aug.; 58: 2414-2419.   
Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
Microbiol.Immunol.(1991) 35(8): 681-686.   
The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice
J. Infect. Dis. (1991) Dec.; 164(6): 1091-1097.   
J. Antibiotics (1989) Dec.; 42(12): 1854-1859.   
Biochem. Biophys. Res. Commun. (1991) Apr.30; 176(2): 805-812.   
Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types I and 2.
J. Virol. (1991) Aug.; 65(8): 4520-4524.   
The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice.
Arch. Virol. (1993) 133(3-4): 259-273.   
J. Antibiotics (Tokyo) (1993) Jun.; 46(6): 1034-1037, No abstruct available.   
Functional expression and characterization of the Epstein -Barr virus DNA polymerase catalytic subunit.
J. Virol. (1993) Aug.,67(8): 4651-4658.   
Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro.
J. Virol. (1993) Dec.; 67(12): 7648-7653.   
Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus.
J. Virol. (1994) May; 68(5): 3354-3363.   
Identification of a target protein of US3 protein kinase of herpes simplex virus type 2.
J. Gen. Virol.(1994) Aug.; 75(Pt 8): 2065-2068.   
Growth and cytopathogenicity of herpes simplex virus in a macrophage cell line, RAW 264: a good indicator of intraperitoneal pathogenicity.
Microbiol.Immunol.(1995) 39(11): 905-909.   
Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.
J. Virol. (1996) Apr.; 70(4): 2237-2246.   
Biochem.Biophys. Res. Commun. (1997) Sep. 8; 238(1): 33-38.   
The product of the US10 gene of herpes simplex virus type 1 is a capsid/tegument-associated phosphoprotein which copurifies with the nuclear matrix.
J. Gen. Virol. (1997) Nov.; 78: 2923-2931.   
Overexpression, purification, and herix-destabilizing properties of Epstein-Barr virus single stranded DNA-binding protein.
J. Gen. Virol. (1998) May; 79(Pt 5): 1257-1264.   
Mode of action of ( 1'S, 2'R)-9-[[1', 2'-Bis-(hydroxymethyl) cycloprop-1'-yl] methyl] guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Antimicrob.Agents Chemother. (1998) Aug.; (8)42: 2095-2102.   
Characterization of the UL55 gene product of herpes simplex virus type 2.
J. Gen. Virol. (1998) Aug.; 79(Pt 8): 1989-1995.   
Characterization of the herpes simplex virus type 2 (HSV-2)US2 gene product and a US2-deficient HSV-2 mutant.
J. Gen. Virol. (1998) Nov.79(Pt 11): 2777-2784.   
Identification and characterization of the herpes simplex virus type 1 UL51 gene product.
J. Gen. Virol. (1998) Dec.; 79(Pt 12): 3027-3031.   
Identification and characterization of the UL14 gene product of herpes simplex virus type 2.
Journal of General Virology, (1999) Sep.; 80(Pt 9): 2423-2431   
Mitochondrial distribution and function in herpes simplex virusinfected cells.
Journal of General Virology, Feb.; 81(Pt 2):401-406(2000)   
The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defense mechanisms during primary infection.
J. Gen. Virol. 2000 Jul.; 81 Pt 7: 1763-1771   
The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopment.
J. Gen. Virol. 2000 Oct.; 81 Pt 10: 2397-2405   
Memory-type CD8+ T cells protect IL-2 receptor alpha-deficient mice from systemic infection with herpes simplex virus type 2.
J. Immunol. 2000 Oct. 15; 165 (8): 4552-4560   

Misc

 
[Mechanism of action of antiviral agents].
Shiraki K, Daikoku T
Nihon rinsho. Japanese journal of clinical medicine   70(4) 536-543   Apr 2012   [Refereed]
[Mechanism of action of antiviral drugs].
Shiraki K, Daikoku T, Takemoto M, Himaki T, Kuramoto T
Nihon rinsho. Japanese journal of clinical medicine   70(4) 545-551   Apr 2012   [Refereed]
The functions of alpha herpesvirus gene products.
Nippon Rinsho. 2000 Apr.; 58 (4): 787-793   

Research Grants & Projects

 
Gene function of herpes virus Growth mechanism of herpes virus